EIGR Shares Outstanding History
Below is a table of the EIGR shares outstanding history going back to 3/23/2016:

Date EIGR Shares Outstanding
3/23/20161.59M
3/31/20166.95M
8/4/20167.10M
11/3/20168.36M
3/16/20178.36M
5/4/20178.37M
8/3/20178.37M
11/3/201710.52M
3/2/201810.53M
5/7/201810.54M
8/6/201814.24M
11/5/201819.10M
3/11/201919.26M
5/6/201924.44M
8/5/201924.45M
11/4/201924.50M
3/5/202024.56M
5/4/202025.06M
8/3/202029.24M
11/2/202032.53M
3/5/202133.90M
5/3/202133.95M

Also see: EIGR Market Cap History
EIGR YTD Return
EIGR Historical Shares Outstanding:
+81.83% CAGR
EIGR Historical Shares Outstanding: +81.83% CAGR

Mouse over chart for data details
3/23/2016 ...5/3/2021
Eiger BioPharmaceuticals is a biopharmaceutical company. Co. has five product candidate pipeline programs: Lonafarnib (LNF) in Hepatitis Delta Virus (HDV), which is an orally bioavailable, farnesylation inhibitor for HDV infection; Peginterferon Lambda in HDV, which is a type III interferon that stimulates immune responses that are key for the development of host protection during viral infections; LNF in Progeria and Progeroid Laminopathies (PL), in which it is developing LNF for treatment of Progeria and PL; Avexitide in Post-Bariatric Hypoglycemia (PBH), in which it is developing as a treatment for PBH; and Avexitide in Congenital Hyperinsulinism (CHI), which is a treatment for CHI. We show 22 historical shares outstanding datapoints in our coverage of EIGR's shares outstanding history.

Understanding the changing numbers of EIGR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like EIGR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching EIGR by allowing them to research EIGR shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for EIGR:
EIGR SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Eiger BioPharmaceuticals (EIGR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

EKSO Shares Outstanding History
ELGX Shares Outstanding History
ENDP Shares Outstanding History
ENSG Shares Outstanding History
ENTA Shares Outstanding History
ENZ Shares Outstanding History
EPZM Shares Outstanding History
ESPR Shares Outstanding History
ESRX Shares Outstanding History
EVFM Shares Outstanding History
More Healthcare companies »

 

EIGR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.